eGFR Improved From 55 To 70 What Does It Mean

eGFR improved from 55 to 70? Learn why confirmation, related tests, and longer-term trend tracking matter more than one value.

An eGFR improvement from 55 to 70 can feel encouraging, but it still needs context. eGFR is an estimate, and estimates can move when creatinine changes for temporary reasons. The useful question is whether this improvement repeats, whether urine markers are stable, and whether the broader kidney trend supports the change.

What This Change Usually Means

This change usually means the estimated kidney filtration rate is higher on the newer report. eGFR is commonly calculated from creatinine and may also be calculated with cystatin C. Because creatinine can move with hydration, exercise, diet, muscle mass, pregnancy, illness, and medicines, a higher eGFR may reflect true improvement, temporary variation, or a mix of both.

Use the range printed on your own lab report. eGFR is reported in mL/min/1.73 m\u00b2; a value greater than 90 is commonly considered in the normal range, and eGFR tends to decline with age. KDIGO GFR categories include G1 at 90 or higher, G2 at 60-89, G3a at 45-59, G3b at 30-44, G4 at 15-29, and G5 below 15 mL/min/1.73 m\u00b2. Chronic kidney disease is defined by kidney function abnormality, such as eGFR below 60 or kidney damage markers, that persists for at least 3 months. In the KDIGO category framework, 55 falls within G3a and 70 falls within G2, but staging depends on persistence, albuminuria, and clinical context.

An improving eGFR trend is strongest when creatinine moved in the expected direction, urine albumin is not worsening, urinalysis is stable, and the result is repeated. One better-looking report is a useful data point, not the whole story.

First, Confirm It Is A Real Change

First confirm that the eGFR values are calculated and reported in the same unit, mL/min/1.73 m\u00b2. eGFR is not directly measured in routine reports; it is estimated from creatinine, and sometimes cystatin C, so formula and assay differences matter.

A recheck can be useful when the result does not fit the rest of the report or the clinical story. Hydration, acute illness, exercise, diet, muscle mass, pregnancy, and medicine changes can move creatinine, which then moves creatinine-based eGFR.

Possible Reasons For The Rise/Fall

eGFR can improve when a temporary contributor resolves. Examples include better hydration, recovery from acute illness, improved kidney blood flow, medication review, or relief of a reversible obstruction when that applies.

Creatinine can rise with dehydration, a large meat or high-protein intake, creatine supplements, intense exercise, high muscle mass, muscle breakdown, and medicines such as NSAIDs, trimethoprim, or cimetidine. If one of these raised creatinine on the earlier report, the later eGFR may look better once the temporary factor is gone.

Cystatin C is less affected by muscle mass, age, sex, and diet than creatinine. KDIGO 2024 recommends combining creatinine and cystatin C for eGFR when available, because the combined estimate can improve risk classification. If creatinine-based eGFR improved but the clinical picture is unclear, cystatin C may help your clinician judge whether the improvement is likely to reflect filtration rather than creatinine production changes.

Why Trends Matter More Than One Result

Improvement is best judged as a trend, not a celebration of one number. A single higher eGFR may be affected by hydration, assay differences, formula inputs, muscle mass, diet, or recent illness.

Repeated improvement across reports, especially with stable or improving creatinine and no worsening urine albumin, is more meaningful. If eGFR rises once and then returns to the prior range, the interpretation changes.

This is where MediLens adds value: it lets you see whether 55 to 70 is a sustained movement, a rebound after a temporary event, or one point in a longer mixed pattern.

When To Talk With A Doctor

Talk with a doctor about what changed between the two reports, especially if you had dehydration, acute illness, a medication change, urinary symptoms, or known kidney disease. Ask whether repeat eGFR, cystatin C, UACR, urinalysis, and BUN should be used to confirm the direction.

Do not stop follow-up only because one eGFR result improved. If prior eGFR was below 60 or urine markers were abnormal, your clinician may still want to confirm whether kidney function abnormality persisted or resolved.

Frequently Asked Questions

Does eGFR improving from 55 to 70 mean my kidneys recovered? It may be encouraging, but one improvement does not prove recovery. Repeat testing, urine markers, creatinine, cystatin C when available, and clinical context matter.

What KDIGO categories include 55 and 70? In the KDIGO GFR framework, 55 is in G3a and 70 is in G2. Staging still depends on persistence and kidney damage markers such as albuminuria.

Can hydration improve eGFR? Hydration can affect kidney blood flow and creatinine, which can change creatinine-based eGFR.

Can creatinine changes explain better eGFR? Yes. Many eGFR results are calculated from creatinine, so a lower creatinine can produce a higher eGFR estimate.

Should I check UACR if eGFR improved? Yes, ask your doctor. UACR can show urine albumin leakage and adds kidney context beyond eGFR.

Can cystatin C confirm the trend? It can help in selected cases. KDIGO supports combined creatinine-cystatin C eGFR when available because it can improve risk classification.

Should follow-up stop after eGFR improves? Follow-up depends on your history, repeat results, urine markers, and clinician guidance. One improved result should be placed in the full trend.

Why are trends better than one improved result? A trend shows whether improvement is sustained or temporary. One result can be affected by assay differences and biological variation.

How MediLens Helps Track Trends

MediLens helps you place the 55 and 70 eGFR results on a timeline with creatinine, UACR, urinalysis, BUN, and cystatin C when present. That makes it easier to tell whether the change is sustained.

You can also document what changed between reports, such as illness recovery, hydration, medicine changes, or urinary symptoms. Those notes help your clinician interpret the improvement without guessing from memory.

Key Takeaways

An eGFR rise from 55 to 70 can be encouraging but needs confirmation.
eGFR is estimated, so creatinine and assay context matter.
KDIGO categories help frame the numbers, but persistence and urine markers matter too.
Repeat results and related tests are more useful than one improved value.
MediLens helps show whether the improvement is sustained over time.

This article is for general education, based on KDIGO clinical practice guidelines and public materials from the National Kidney Foundation (NKF). It is not a diagnosis or treatment advice and does not replace your doctor. Interpret results using the reference ranges on your own lab report and your physician's guidance.

A single lab result only tells part of the story. MediLens helps you scan lab reports, organize your results, compare changes over time, and better understand your long-term health trends.